Biologic drugs, including proteins, peptides, antibodies, and other large molecules, have transformed healthcare by enabling highly targeted treatment for chronic and complex diseases. However, their delivery has remained a major challenge because these therapies are typically unstable in the gastrointestinal tract and often require injections.
At CuriOralRx, we have developed innovative oral delivery technologies that overcome these barriers and enable next-generation therapeutic solutions.
One of the greatest barriers to oral biologic delivery is protecting delicate therapeutic molecules from harsh stomach acid, digestive enzymes, and environmental degradation.
Our advanced formulation technology helps:
By stabilizing biologic compounds effectively, we help ensure therapies reach their intended destination intact and functional.
Even if a biologic drug survives the stomach, it still faces a major challenge in reaching the bloodstream. Large molecules like peptides and proteins struggle to pass through the intestinal barrier.
Our platform is designed to improve targeted absorption by supporting controlled and efficient transport of biologic molecules across the intestinal lining. This helps increase the chances of meaningful systemic exposure after oral administration.
Another key barrier in oral biologic delivery is the tight structure of the intestinal wall, which naturally limits the passage of large molecules.
Our approach focuses on transient permeability enhancement, which helps temporarily improve the ability of the intestinal lining to allow biologic drugs to pass through safely and effectively.
This controlled and temporary mechanism is designed to support absorption without long-term disruption to normal biological function.
